US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...

CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...

California-based Renasant Bio announced its launch to advance next-generation disease-modifying treatments for autosomal ...

The National Institute for Health and Care Excellence (NICE) has published final guidance recommending Eli Lilly’s Omvoh ...

Sino-American biopharma Ascentage Pharma announced that its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575 ...

Chinese cell therapy developer NK CellTech has raised nearly 100 million renminbi ($14 million) in an extended series A+++ ...

Lewy body dementia (LBD) remains one of the most overlooked and complex neurodegenerative conditions, but momentum is ...

Nuclidium, a radiopharma company developing a proprietary copper-based theranostic platform, has announced the successful ...

Shares in US biotech Ultragenyx Pharmaceutical (Nasdaq: RARE) and its UK-based partner Mereo BioPharma (Nasdaq: MREO) tumbled ...

BrainXell, a US biotechnology company developing iPSC-based CNS disease models and regenerative cell therapies, has announced ...

The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...